State Street’s Oragenics OGEN Stock Holding History

State Street’s Portfolio OGEN Stock Details OGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-275	Closed	-$52.1K	–	4813
2022 Q4	$52.1K	Hold	275	–	–	﹤0.01%	4550
2022 Q3	$112K	Hold	275	–	–	﹤0.01%	4428
2022 Q2	$172K	Hold	275	–	–	﹤0.01%	4277
2022 Q1	$171K	Buy	275 +20	+8%	+$14.7K	﹤0.01%	4441
2021 Q4	$204K	Hold	255	–	–	﹤0.01%	4343
2021 Q3	$291K	Buy	255 +3	+1%	+$3.62K	﹤0.01%	4214
2021 Q2	$321K	Buy	+252	New	+$332K	﹤0.01%	4025

Other funds holding OGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Northwestern Mutual Wealth Management Milwaukee, Wisconsin $187B AUM 21.7% 1-Year Est. Return

WWM

Wolff Wiese Magana Carslbad, California $217M AUM 47.64% 1-Year Est. Return

State Street's OGEN Position: Q1 2023 in Review

State Street sold out of Oragenics (OGEN) in Q1 2023, closing a stake of 275 shares — an estimated $52.1K sold.

State Street first reported a position in OGEN in Q2 2021 and held it in 7 quarters. The position peaked at $321K in Q2 2021. 10 funds tracked by Wall St. Rank hold OGEN as of Q1 2023.

State Street reported no remaining Oragenics position as of Q1 2023 after selling out during the quarter.
State Street sold 275 Oragenics shares in Q1 2023, an estimated $52.1K.
State Street first reported a position in Oragenics in Q2 2021 and held it in 7 quarters.
State Street's Oragenics position peaked at $321K in Q2 2021.
10 funds tracked by Wall St. Rank held Oragenics as of Q1 2023.

Based on State Street's 13F filing for Q1 2023, filed 15 May 2023.